These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. Gill PS, Bernstein-Singer M, Espina BM, Rarick M, Magy F, Montgomery T, Berry MS, Levine A. AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520 [Abstract] [Full Text] [Related]
44. Ganciclovir implants: one year later. Cadman J. GMHC Treat Issues; 1997 Dec; 11(4/5):3-6. PubMed ID: 11364375 [Abstract] [Full Text] [Related]
45. Treatment of cytomegalovirus retinitis with zidovudine and ganciclovir in patients with AIDS: outcome and toxicity. Millar AB, Miller RF, Patou G, Mindel A, Marsh R, Semple SJ. Genitourin Med; 1990 Jun; 66(3):156-8. PubMed ID: 2164492 [Abstract] [Full Text] [Related]
46. [Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]. Gorin NC, Coiffier B, Hayat M, Fouillard L, Kuentz M, Flesch M, Colombat P, Boivin P, Slavin S, Lemarié JC. Presse Med; 1993 Jan 30; 22(3):109-20. PubMed ID: 8493215 [Abstract] [Full Text] [Related]
48. [Treatment with a combination of G-CSF and ganciclovir in a patient with retinitis caused by cytomegalovirus and AIDS]. García-Díez F, Hermida I, Pascual A, Arazo P, Losfablos F. Enferm Infecc Microbiol Clin; 1994 Nov 30; 12(9):468. PubMed ID: 7529052 [No Abstract] [Full Text] [Related]
49. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Walton RC, Whitcup SM, Mueller BU, Lewis LL, Pizzo PA, Nussenblatt RB. Ophthalmology; 1995 Dec 30; 102(12):1865-70. PubMed ID: 9098289 [Abstract] [Full Text] [Related]
50. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy. Bregni M, Siena S, Di Nicola M, Dodero A, Peccatori F, Ravagnani F, Danesini G, Laffranchi A, Bonadonna G, Gianni AM. J Clin Oncol; 1996 Feb 30; 14(2):628-35. PubMed ID: 8636780 [Abstract] [Full Text] [Related]
51. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG). Am J Ophthalmol; 1997 Jul 30; 124(1):61-70. PubMed ID: 9222234 [Abstract] [Full Text] [Related]
53. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group. Bunn PA, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR. J Clin Oncol; 1995 Jul 30; 13(7):1632-41. PubMed ID: 7602352 [Abstract] [Full Text] [Related]
54. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. Drew WL, Ives D, Lalezari JP, Crumpacker C, Follansbee SE, Spector SA, Benson CA, Friedberg DN, Hubbard L, Stempien MJ. N Engl J Med; 1995 Sep 07; 333(10):615-20. PubMed ID: 7637721 [Abstract] [Full Text] [Related]
56. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med; 1995 Jan 09; 155(1):65-74. PubMed ID: 7802522 [Abstract] [Full Text] [Related]
58. The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir. Berman SM, Kim RC. Am J Med; 1994 May 09; 96(5):415-9. PubMed ID: 8192172 [Abstract] [Full Text] [Related]